A new program helps patients safely transition off GLP-1 medications while maintaining results through nutrition, ...

The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

The U.S. Food and Drug Administration (FDA) has approved a once-daily GLP-1 pill for weight loss called orforglipron, and ...

Green-lit within 50 days of filing, orforglipron marks the first approval of a new molecular entity under the FDA ...

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

Orforglipron is a GLP-1 drug that works like widely used injectable medications to mimic a natural hormone that controls appetite and feelings of fullness.

The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting ​up its next battle with rival Novo Nordisk for the ...

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

Shed pounds and move better than ever. All you have to do is take a first step.

In TODAY.com's Expert Tip of the Day, a dietitian shares the dieting red flag she looks for in a weight loss program.

Weight-loss clinics have opened at a steady pace across upstate New York over the past few years. From Geneva to Canandaigua, ...